Tilray adds dronabinol to German product portfolio

MJBizDaily
By Alfredo PascualDec 1, 2020, 1:13 pm220 pts
Canadian cannabis producer Tilray is offering dronabinol in the German medical cannabis market, according to a notice in the German trade publication Apotheke Ad-Hoc. Tilray’s dronabinol is plant-derived – like most, if not all, of the dronabinol available in Germany. The notice says Tilray sources the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

From ‘sin taxes’ to potency pricing: Modern approaches to excise tax policy 72

We Need To Debunk Marijuana Rescheduling Myths As Trump Weighs Action (Op-Ed) 71

Using Cannabis Seeds During The Beer Brewing Process ‘Enhances The Nutritional Value,’ Study Shows 70

TerrAscend Renews, Replenishes $10M Share Repurchase Program 63

Federal Agent Warns DC Residents Trump Is ‘Tired Of’ Public Marijuana Consumption Amid ‘Surge’ To Combat Crime In Nation’s Capitol 62

FLUENT Partners With Connected Cannabis at its New Cultivation Facility in New York 61

Goldflower Cannabis Opening 10th Florida Medical Dispensary in Lakeland 58

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.